Incannex Healthcare (IXHL) EBT Margin (2024)
Incannex Healthcare's (IXHL) quarterly EBT Margin came in at 49116.67% in Q4 2024, down 570.6% quarter-over-quarter from 7324.32% in Q3 2024.
Incannex Healthcare (IXHL) EBT Margin (2024) Analysis & Trends
Incannex Healthcare has disclosed EBT Margin across 1 years of filings, most recently posting 49116.67% for Q4 2024.
- EBT Margin for Q4 2024 came in at 49116.67%, changed N/A year-over-year; the trailing twelve-month figure through Jun 2025 was 54517.44% (changed N/A YoY), and the FY2025 annual result was 54517.44%, up 9905756.0% from the prior year.
- EBT Margin came in at 49116.67% for Q4 2024 at Incannex Healthcare, down from 7324.32% in the prior quarter.
- In the past five years, EBT Margin ranged from a high of 7324.32% in Q3 2024 to a low of 49116.67% in Q4 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn | 10.97% |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn | 33.51% |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn | 40.73% |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn | 25.87% |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn | 30.30% |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn | 6.35% |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn | -156.77% |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn | -16.70% |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn | 41.45% |
| 10 | Incannex Healthcare | 45.81 Mn | 45.81 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | -49,116.67% |
| Sep 30, 2024 | -7,324.32% |